First Phosphate clears warrants, boosts treasury to fund feasibility study

About this episode

John Passalacqua discusses First Phosphate's successful warrant exercise and its implications for the company's financial strategy.

First Phosphate Corp. CEO John Passalacqua joined Steve Darling from Proactive to discuss the successful completion of a $3 million warrant exercise, a move that leaves the company effectively warrant-free while significantly strengthening its financial position and simplifying its capital structure. Passalacqua explained that the final tranche of client and broker warrants—exercised at $1.25—was taken up by long-term shareholders just ahead of expiry. He noted that this level of participation reflects strong investor confidence in the company’s strategy and long-term vision. With these warrants now cleared, First Phosphate has streamlined its capitalization table, with any remaining potential dilution limited to holdings by management, staff, and the board, aligning insiders more closely with shareholder interests. The additional $3 million further bolsters what was already a solid treasury position, bringing total available capital to approximately $23 million. This financial strength is complemented by a recently secured $16.7 million non-dilutive, non-reimbursable contribution from the Government of Canada. The funding is earmarked to support the development of a concentrator…

People in this episode

Host: Steve Darling

Guest: John Passalacqua

Topics covered

• warrant exercise
• financial position
• investor confidence
• capital structure
• battery materials
• lithium iron phosphate

Keywords

• First Phosphate
• warrant exercise
• financial strength
• lithium iron phosphate
• capital structure
• investor confidence
• Government of Canada
• battery materials

Mentioned in this episode

Organizations: First Phosphate Corp., Government of Canada

Places: Québec

More episodes of Proactive - Interviews for investors

• Regan Capital CIO on bond market opportunities in a rising rate environment · June 12, 2026 · 6 min
• Light Science Technologies lifts capacity 50% with new SMT line and global client win · June 12, 2026 · 5 min
• Poolbeg Pharma launches POLB 001 TOPICAL trial to tackle CAR-T side effects · June 12, 2026 · 4 min
• Lumos Diagnostics expands FebriDx adoption across 100+ US healthcare sites with CLIA Waiver · June 11, 2026 · 8 min
• Flow Metals advances drill-ready Yukon gold project while expanding Copper exploration in B.C. · June 11, 2026 · 6 min
• Midstream energy sector positioned for growth as LNG and AI drive demand · June 11, 2026 · 7 min